Skip to main content
. 2019 Feb 24;47(4):1731–1739. doi: 10.1177/0300060519829991

Figure 3.

Figure 3.

Effect of alteplase treatment on the levels of platelet surface receptors GPIbα, GPVI and αIIbβ3. Following treatment of platelets with different concentrations of alteplase (1, 10, 100 or 200 μg/ml) for 60 min at 37°C, the surface levels of GPIbα, GPVI and αIIbβ3 were measured using flow cytometry and fluorescein isothiocyanate (FITC)-conjugated mouse anti-human CD42b antibody (GPIbα; a), mouse anti-human GPVI antibody (detected using FITC-conjugated goat anti-mouse IgG; b) or FITC-conjugated mouse anti-human CD41a antibody (αIIb) (c). Data presented as mean ± SD.